Renu Bhatia is the Chairman of the Listing Committee of Hong Kong Stock Exchange and Deputy Chairman of HKEX Listing Committee. With a strong background in entrepreneurship and investment, Renu co-founded Opharmic Technology, focusing on non-invasive drug delivery technology for the eye. Renu is also involved in various advisory roles and committees in organizations such as ITF, Asia Fintech Angels, and Cyberport Hong Kong. In addition, Renu holds positions on the boards of organizations like Garsington Technologies Ltd and TIE HK, showcasing their dedication to the business and technology sectors. With an MBA from Yale School of Management and a medical background from University of London, Renu brings a unique blend of expertise to their various roles in the industry.
Sign up to view 0 direct reports
Get started